Table 2:
Clinical features of patients with pneumothorax
| Cases | Day of pneumothorax development after intensive care unit admission | Day of pneumothorax development after intubation | Location of pneumothorax | Drainage | Air leak | Chest tube follow-up duration (days) | Right (%) | Left (%) | Comorbid diseases |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | 3 | L | 0 | 1 | 2 | 15.3 | CAD | |
| 2 | 3 | 1 | L | 200 | 0 | 15 | 50.8 | HT | |
| 3 | 4 | 4 | R | 200 | 0 | 5 | 42.4 | Chronic HB | |
| 4 | 8 | 8 | R | 0 | 0 | 6 | 31.7 | None | |
| 5 | 4 | 4 | R | 1500 | 0 | 2 | 139.0 | None | |
| 6 | 15 | 15 | R | 300 | 0 | 6 | 41.8 | CAD | |
| 7 | 4 | 1 | R | 100 | 0 | 10 | 61.5 | Epilepsy, CD | |
| 8 | 25 | 25 | RL | 200 | 1 |
R (5) L (12) |
30.9 | 31.5 | Gout, BPH |
BPH: benign prostatic hyperplasia; CAD: coronary artery disease; CD: cerebrovascular disease; HB: hepatitis B; HT: hypertension.